ID

38925

Descripción

Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01541215

Link

https://clinicaltrials.gov/show/NCT01541215

Palabras clave

Versiones (1)
  1. 13/11/19 13/11/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

13 de noviembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes NCT01541215

Inglés

Eligibility Diabetes NCT01541215

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01541215
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
children and adolescents between the ages of 10-16 years. subjects cannot turn 17 years and 11 months before the end of treatment (52 weeks)
Descripción

Children | Adolescents | Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0008059
UMLS CUI [2]
C0205653
UMLS CUI [3]
C0001779
diagnosis of type 2 diabetes mellitus and treated for at least 30 days with: diet and exercise alone, diet and exercise in combination with metformin monotherapy, diet and exercise in combination with metformin and a stable (stable is defined as basal insulin adjustments up to 15%) dose of basal insulin, diet and exercise in combination with a stable (stable is defined as basal insulin adjustments up to 15%) dose of basal insulin
Descripción

Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | Exercise | Combined Modality Therapy | Metformin | Basal insulin Dose Stable

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0178602
UMLS CUI [2,2]
C0205360
hba1c: 7.0-11% (inclusive) if diet and exercise treated or 6.5-11% (inclusive) if treated with metformin as monotherapy, basal insulin as monotherapy or metformin and basal insulin in combination
Descripción

Hemoglobin A1c measurement | Diet therapy | Exercise | Metformin | Basal insulin | Combined Modality Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0474680
UMLS CUI [2]
C0012159
UMLS CUI [3]
C0015259
UMLS CUI [4]
C0025598
UMLS CUI [5]
C0650607
UMLS CUI [6]
C0009429
body mass index (bmi) above 85% percentile of the general age and gender matched population
Descripción

Body mass index | Age | Gender

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0079399
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes
Descripción

Diabetes Mellitus, Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011854
maturity onset diabetes of the young (mody)
Descripción

Maturity onset diabetes mellitus in young

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0342276
use of any antidiabetic agent other than metformin and/or basal insulin within 90 days prior to screening
Descripción

Antidiabetics | Exception Metformin | Exception Basal insulin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0935929
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0025598
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0650607
recurrent severe hypoglycaemia or hypoglycaemic unawareness as judged by the investigator
Descripción

Recurrent severe hypoglycemia | Loss of hypoglycemic warning

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0342316
UMLS CUI [2]
C0342317
history of chronic pancreatitis or idiopathic acute pancreatitis
Descripción

Pancreatitis, Chronic | Idiopathic acute pancreatitis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149521
UMLS CUI [2]
C0341461
any clinically significant disorder, except for conditions associated with type 2 diabetes history which in the investigator's opinion could interfere with results of the trial
Descripción

Disease Interferes with Research results | Exception Condition Associated with Non-Insulin-Dependent Diabetes Mellitus

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0683954
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0348080
UMLS CUI [2,3]
C0332281
UMLS CUI [2,4]
C0011860
uncontrolled hypertension, treated or untreated above 99th percentile for age and gender in children
Descripción

Uncontrolled hypertension Treated | Uncontrolled hypertension Untreated | Age Children | Gender Children

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1868885
UMLS CUI [1,2]
C1522326
UMLS CUI [2,1]
C1868885
UMLS CUI [2,2]
C0332155
UMLS CUI [3,1]
C0001779
UMLS CUI [3,2]
C0008059
UMLS CUI [4,1]
C0079399
UMLS CUI [4,2]
C0008059
known or suspected abuse of alcohol or drugs/narcotics
Descripción

Substance Use Disorders | Substance Use Disorders Suspected | Narcotic Abuse | Narcotic Abuse Suspected

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2,1]
C0038586
UMLS CUI [2,2]
C0750491
UMLS CUI [3]
C0524661
UMLS CUI [4,1]
C0524661
UMLS CUI [4,2]
C0750491
Volver a la parte superior de la página

Similar models

Eligibility Diabetes NCT01541215

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01541215
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Children | Adolescents | Age
Item
children and adolescents between the ages of 10-16 years. subjects cannot turn 17 years and 11 months before the end of treatment (52 weeks)
boolean
C0008059 (UMLS CUI [1])
C0205653 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | Exercise | Combined Modality Therapy | Metformin | Basal insulin Dose Stable
Item
diagnosis of type 2 diabetes mellitus and treated for at least 30 days with: diet and exercise alone, diet and exercise in combination with metformin monotherapy, diet and exercise in combination with metformin and a stable (stable is defined as basal insulin adjustments up to 15%) dose of basal insulin, diet and exercise in combination with a stable (stable is defined as basal insulin adjustments up to 15%) dose of basal insulin
boolean
C0011860 (UMLS CUI [1])
C0178602 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
Hemoglobin A1c measurement | Diet therapy | Exercise | Metformin | Basal insulin | Combined Modality Therapy
Item
hba1c: 7.0-11% (inclusive) if diet and exercise treated or 6.5-11% (inclusive) if treated with metformin as monotherapy, basal insulin as monotherapy or metformin and basal insulin in combination
boolean
C0474680 (UMLS CUI [1])
C0012159 (UMLS CUI [2])
C0015259 (UMLS CUI [3])
C0025598 (UMLS CUI [4])
C0650607 (UMLS CUI [5])
C0009429 (UMLS CUI [6])
Body mass index | Age | Gender
Item
body mass index (bmi) above 85% percentile of the general age and gender matched population
boolean
C1305855 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Maturity onset diabetes mellitus in young
Item
maturity onset diabetes of the young (mody)
boolean
C0342276 (UMLS CUI [1])
Antidiabetics | Exception Metformin | Exception Basal insulin
Item
use of any antidiabetic agent other than metformin and/or basal insulin within 90 days prior to screening
boolean
C0935929 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0650607 (UMLS CUI [3,2])
Recurrent severe hypoglycemia | Loss of hypoglycemic warning
Item
recurrent severe hypoglycaemia or hypoglycaemic unawareness as judged by the investigator
boolean
C0342316 (UMLS CUI [1])
C0342317 (UMLS CUI [2])
Pancreatitis, Chronic | Idiopathic acute pancreatitis
Item
history of chronic pancreatitis or idiopathic acute pancreatitis
boolean
C0149521 (UMLS CUI [1])
C0341461 (UMLS CUI [2])
Disease Interferes with Research results | Exception Condition Associated with Non-Insulin-Dependent Diabetes Mellitus
Item
any clinically significant disorder, except for conditions associated with type 2 diabetes history which in the investigator's opinion could interfere with results of the trial
boolean
C0012634 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0348080 (UMLS CUI [2,2])
C0332281 (UMLS CUI [2,3])
C0011860 (UMLS CUI [2,4])
Uncontrolled hypertension Treated | Uncontrolled hypertension Untreated | Age Children | Gender Children
Item
uncontrolled hypertension, treated or untreated above 99th percentile for age and gender in children
boolean
C1868885 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C1868885 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C0001779 (UMLS CUI [3,1])
C0008059 (UMLS CUI [3,2])
C0079399 (UMLS CUI [4,1])
C0008059 (UMLS CUI [4,2])
Substance Use Disorders | Substance Use Disorders Suspected | Narcotic Abuse | Narcotic Abuse Suspected
Item
known or suspected abuse of alcohol or drugs/narcotics
boolean
C0038586 (UMLS CUI [1])
C0038586 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0524661 (UMLS CUI [3])
C0524661 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial